Referral Process: Streamlining and Challenges Seen
Medical experts discuss streamlining referrals to reduce treatment delays, optimizing resources, comparing outcomes in collaborative vs noncollaborative settings, and managing patient reluctance about academic center referrals.v
EP: 1.Importance of Collaboration between Academic and Community Centers
Now Viewing
EP: 2.Referral Process: Streamlining and Challenges Seen
EP: 3.Referral Process: Bispecifics
EP: 4.Similarities and Differences among Bispecifics: BCMA vs non-BCMA
EP: 5.Types of Referrals and Impact of Social Factors on the Referral Process
EP: 6.Managing AEs Seen with Bispecifics
EP: 7.Referral Process: CAR T-Cell Therapy
EP: 8.CAR T: Impact of Recent Approvals on the Referral Process
EP: 9.Long-Term Monitoring of AEs and Reintegrating Patients back into Community Care
EP: 10.Clinical Pearls about the Referral Process of Bispecifics and CAR-T in RRMM
Video content above is prompted by the following:
How can we streamline the referral process to reduce delays between initial patient identification and treatment initiation?
What additional resources or support would be most helpful in optimizing the referral process for these therapies?
Do you see a difference in patient outcomes when treated in a collaborative setting vs not?
What are some challenges you are currently seeing?
How do you handle cases where patients are reluctant to be referred to an academic center?
Recent Videos
Related Content
